| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
74 Outperform | £817.01M | 8.94 | 7.83% | 6.51% | -1.35% | -12.67% | |
73 Outperform | £1.33B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
67 Neutral | £292.39M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
64 Neutral | £35.56M | 4.08 | 4.60% | ― | 17.79% | 18.96% | |
63 Neutral | £500.04M | 11.70 | 7.92% | ― | 13.21% | -54.35% | |
56 Neutral | £639.05M | 8.84 | -113.93% | 1.40% | 3.94% | ― |